Trinity Biotech plc (TRIB) Ownership
TRIB ownership summary
as of October 18, 2026- Institutions
- 3.4% of shares outstanding
- Insiders
- 13.81% of shares outstanding
- Shares outstanding
- 813K
- Float
- 559K shares available to trade
- Short interest
- 5.64% 18K shares short
- Days to cover
- 1.56 short interest up 123.3% vs prior month
- Institutions 3.39%
- Insiders 13.81%
- Other investors 82.80%
TRIB top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Hunter Associates Inc. | 2.71% | 661K | $5.3M | +125,000 (+23.3%) | June 30, 2026 |
| 2 | Williams & Novak LLC | 0.58% | 141K | $1.1M | +32,900 (+30.6%) | June 30, 2026 |
| 3 | CAMBRIDGE Invest RESEARCH ADVISORS, INC. | 0.18% | 45K | $357,817 | +22,280 (+100.0%) | June 30, 2026 |
| 4 | Susquehanna International Group, LLP | 0.11% | 27K | $215,678 | +26,859 (0.0%) | June 30, 2026 |
| 5 | Moss Adams Wealth Advisors LLC | 0.11% | 26K | $206,098 | — | June 30, 2026 |
| 6 | Integrys Wealth Advisors LLC | 0.10% | 25K | $200,750 | — | June 30, 2026 |
| 7 | Becker Capital | 0.07% | 18K | $144,540 | — | June 30, 2026 |
| 8 | LPL Financial Corp | 0.07% | 18K | $141,874 | +2,632 (+17.5%) | June 30, 2026 |
| 9 | Geode Capital Management, LLC | 0.05% | 13K | $101,162 | −4,044 (−24.3%) | June 30, 2026 |
| 10 | Rhumbline Advisers | 0.04% | 9,369 | $75,233 | +3,822 (+68.9%) | June 30, 2026 |
| 11 | Advisor Group Holdings, Inc. | 0.01% | 3,500 | $28,105 | +3,500 (0.0%) | June 30, 2026 |
| 12 | Wells Fargo & Co | 0.01% | 2,500 | $20,075 | — | June 30, 2026 |
| 13 | UBS Group AG | <0.01% | 1,107 | $8,889 | +100 (+9.9%) | June 30, 2026 |
| 14 | Morgan Stanley - Brokerage Accounts | <0.01% | 400 | $3,212 | −2 (−0.5%) | June 30, 2026 |
| 15 | SIMPLEX TRADING, LLC | <0.01% | 354 | $2,843 | −201 (−36.2%) | June 30, 2026 |
| 16 | Atwood & Palmer Inc | <0.01% | 20 | $161 | — | June 30, 2026 |
| 17 | Mcilrath & Eck, LLC | 0.00% | 5 | $40 | +5 (0.0%) | March 31, 2026 |
| 18 | Triumph Capital Management | 0.00% | — | — | −1,000 (−100.0%) | June 30, 2026 |
| 19 | Yorkville Advisors Global, LP | 0.00% | — | — | −225,000 (−100.0%) | June 30, 2026 |
| 20 | JONES FINANCIAL COMPANIES LLLP | 0.00% | — | — | −3,804 (−100.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 9 holders added 217K shares and 6 cut 234K.
TRIB top mutual fund and ETF holders
1 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Nasdaq Composite Index | 0.05% | 419 | $3,365 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
TRIB shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns TRIB
Institutional investors own 3.4% of Trinity Biotech's shares and insiders 13.81%. The largest holder is Hunter Associates Inc. with 2.71% of the shares (661K), as of June 30, 2026. Among the top 20 institutions, 9 added shares and 6 reduced their stake in the latest filings. Short interest is 5.64% of the float, or 1.56 days of average trading volume. The share count rose 1,493.6% since 2014.
Related: TRIB analyst forecast, TRIB key metrics. See the TRIB stock overview for the latest quote and news.
TRIB ownership FAQ
Who owns the most Trinity Biotech stock?
The largest shareholders of Trinity Biotech are Hunter Associates Inc. (2.71%), Williams & Novak LLC (0.58%), CAMBRIDGE Invest RESEARCH ADVISORS, INC. (0.18%), Susquehanna International Group, LLP (0.11%), Moss Adams Wealth Advisors LLC (0.11%).
What percentage of Trinity Biotech is owned by institutions?
Institutions hold 3.4% of Trinity Biotech's shares outstanding; insiders hold 13.81%.
Which funds own Trinity Biotech?
The largest fund holders of Trinity Biotech are Fidelity Nasdaq Composite Index (0.05%).
What is Trinity Biotech's short interest?
18K shares of Trinity Biotech were sold short, 5.64% of the float; at the average daily volume it would take 1.56 days to cover.
How many shares of Trinity Biotech are outstanding?
Trinity Biotech has 813K shares outstanding, of which 559K are in the public float.